Announcements Trials

Browse Landscape

Phase

Phase 4 3 Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Alcohol Drinking 10 Smoking Cessation 4 Neoplasms 4 Smoking 2 Postoperative Complications 2 Pain 2 Depression 2 Condylomata Acuminata 2 Cardiovascular Diseases 2 Agnosia 2 Wounds and Injuries 1 Warts 1 Visceral Pain 1 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Tuberculosis 1 Thyroid Cancer, Papillary 1 Substance-Related Disorders 1 Squamous Cell Carcinoma of Head and Neck 1 Social Isolation 1 Risk-Taking 1 Risk Reduction Behavior 1 Patient Preference 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Pancreatic Intraductal Neoplasms 1 Pancreatic Cyst 1 Obesity 1 Mouth Neoplasms 1 Motor Activity 1

Interventions

Transcutaneous Electric Nerve Stimulation 3 Acupuncture Therapy 3 Transcranial Direct Current Stimulation 2 Pharmaceutical Services 2 Morphine 2 Control Groups 2 Analgesics, Opioid 2 nabiximols 1 Tramadol 1 Therapeutic Touch 1 Telemedicine 1 Surveys and Questionnaires 1 Spinal Cord Stimulation 1 Sodium Bicarbonate 1 Ropivacaine 1 Radiosurgery 1 Radiofrequency Ablation 1 Radiation 1 Pregabalin 1 Patient Education as Topic 1 Passive Cutaneous Anaphylaxis 1 Myofascial Release Therapy 1 Methods 1 Lidocaine 1 Laser Therapy 1 Infusions, Intravenous 1 Imagery, Psychotherapy 1 Hospitals 1 GluN2C-2D antagonist UBP145 1 Ethanol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Cancer Pain × Ethanol × Clear all

NCT06978673 2025-06-03

CONCERN

Instituto do Cancer do Estado de São Paulo

Phase NA Not yet recruiting

Cancer Pain, Agnosia, Neoplasms, Abdominal Pain, Visceral Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡